Epidemiological Study of Subjective Cognitive Decline (SCD) - MISSION SCD

Juntendo University Hospital Eisai Co., Ltd.0 sites100 target enrollmentJuly 1, 2018

Overview

No summary available.

Registry

who.int

Start Date

July 1, 2018

End Date

March 31, 2022

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

Juntendo University Hospital Eisai Co., Ltd.

•(i)A person who is in the state that may affect impaired cognitive function. (ii)A person who has experienced epileptic seizures in the past five years before screening or who is observed to have a disability in the past five years before screening, and it very likely due to epileptic seizures. (iii)A person who had transient ischemic attacks or strokes in the past 12 months before screening. (iv)A person whose revised version of the Hachinski Ischemic Score is 5 or more during screening. (v)A person with mental disorders or mental symptoms that is considered by the study investigator or the study subinvestigator to have the possibility of interfering with the implementation of the study. (vi)A person who uses a cardiac pacemaker, defibrillator, or ferromagnetic metallic implant, which is considered to be a contraindication to MRI testing. (vii)A person who shows a clinically relevant lesion that supports the diagnosis of dementia in MRI testing during screening. Other than the above, a person with a clinically relevant pathological finding other than dementia. (viii)A person whose laboratory results during screening fall into either of the following: A person whose TSH value exceeds the upper limit of the baseline. A person whose vitamin B12 value in serum is abnormally low. (ix)Other than the above, a person who is judged to be inappropriate as a subject by the principle investigator.